Human BID shRNA Lentivirus

SKU:BHV19400147
Catalog / Quick links
    Overview
    Click light‑blue chips for details
    The Human BID shRNA Lentivirus enables stable, high-efficiency knockdown of the BH3-only apoptosis gene BID in human cells. Supplied as high-titer, VSV-G-pseudotyped third-generation particles validated for at least 70% knockdown, it transduces primary and cryopreserved cells and supports stable cell line generation for studying death receptor signaling, mitochondrial apoptosis, and crosstalk between apoptotic pathways.
    Species Human
    Target Gene BID
    Reporter GFP, GFP/Luc, RFP (+1 more)
    Selection Blasticidin, Puromycin
    Accession NM_197966.3
    Validation ≥70% Knockdown Validated
    Format 3rd Gen, VSV-G Pseudotyped
    Available Options

    Select the lentiviral variant that best fits your experiment. Availability and lead time may vary by option.

    • Options:
      • Includes GFP reporter with Puromycin selection; supplied as 5x10^6 (sh-mix) + 5x10^6 (scr-mix) TU.
      • Includes RFP reporter with Blasticidin selection; supplied as 5x10^6 (sh-mix) + 5x10^6 (scr-mix) TU.
      • Includes GFP reporter with Puromycin selection; supplied as 5x10^6 TU.
      • Includes RFP reporter with Blasticidin selection; supplied as 5x10^6 TU.
      • Includes GFP/Luc reporter; supplied as 2x10^6 TU.
      • Includes RFP/Luc reporter; supplied as 2x10^6 TU.
      • Includes GFP reporter with Blasticidin selection; supplied as 5x10^6 TU.
      • Includes RFP reporter with Puromycin selection; supplied as 5x10^6 TU.
      • with Puromycin selection; supplied as 5x10^6 TU.
      • with Blasticidin selection; supplied as 5x10^6 TU.
    • Lead time: typically ships in ~7 business days; timing may vary by selected option.
    • Storage: store at -80°C
    • Shipping: Ships on dry ice
    • Upon receipt: follow the product datasheet storage instructions.
    • Sales terms and conditions: Please review prior to ordering.
    Options selector
    Catalog no. Reporter Selection Amount (TU)
    LSV-0032-SET1 GFP
    LSV-0032-SET2 RFP
    LSV-0032-3S GFP/Luc
    LSV-0032-4S RFP/Luc
    LSV-0032-7S None
    Field Specification
    Accession Number NM_197966.3
    Product Type
    • Lentiviral Vector
    • shRNA Lentivirus
    Reporter GFP, GFP/Luc, N/A, RFP, RFP/Luc
    Selection Marker Blasticidin, N/A, Puromycin
    Shipping Ships on dry ice; store at -80°C
    Species Human

    Background

    BID (BH3 interacting domain death agonist) is a BH3-only member of the BCL-2 protein family that links the extrinsic and intrinsic apoptotic pathways. Following death receptor activation, caspase-8 cleaves BID to generate truncated BID (tBID), which translocates to mitochondria and activates the effectors BAX and BAK. This triggers mitochondrial outer membrane permeabilization, release of cytochrome c, and downstream caspase activation, amplifying the apoptotic signal. By coupling death receptor signaling to the mitochondrial pathway, BID is essential for efficient apoptosis in many cell types. Its regulation influences sensitivity to cell death, and dysregulation contributes to tumorigenesis and therapy resistance.

    Product Description & Applications

    The Human BID shRNA Lentivirus delivers validated short hairpin RNA targeting BID from a third-generation, self-inactivating lentiviral backbone. shRNA expression is driven by a U6 promoter, with a co-expressed fluorescent reporter (GFP or RFP) and antibiotic selection marker. VSV-G pseudotyping enables broad tropism across primary, suspension, and cryopreserved cells, and each shRNA is validated for at least 70% BID knockdown by a fluorescence-based method.

    High-titer particles are ultra-purified by PEG precipitation and sucrose gradient centrifugation. A shRNA set option provides a mix of two independent validated shRNAs plus a scrambled control. Applications include loss-of-function studies of death receptor signaling, mitochondrial apoptosis, and apoptotic crosstalk.

    About This Product

    This validated shRNA lentivirus targeting BID (NCBI Accession: NM_197966.3) delivers a 19–20 bp shRNA from a third-generation, self-inactivating lentiviral backbone. Expression is driven from a U6 Pol III promoter, with a constitutively expressed fluorescent reporter (GFP, GFP/Luc, RFP, RFP/Luc) and antibiotic selection marker (Blasticidin, Puromycin) co-expressed from the same vector. VSV-G pseudotyping enables broad cell tropism, including primary, suspension, and cryopreserved cell types.

    Knockdown is validated using a proprietary bicistronic fluorescence assay in which the target mRNA is co-expressed fused to RFP alongside the shRNA-GFP construct. At least 70% reduction in RFP signal in GFP-positive cells confirms on-target activity — a more direct functional readout than transcript-level qPCR. Polyclonal stable lines can be generated by antibiotic selection within 10 days, preserving parental cell heterogeneity compared to single-clone CRISPR approaches.

    What knockdown efficiency does this shRNA lentivirus achieve?
    How was the shRNA construct validated?
    What reporter and selection marker options are available?
    What cell types are recommended for transduction?
    Is a negative control lentivirus available?

    Can't find the lentiviral construct you need, or want to adjust key design elements? Contact us to discuss custom LV design and optional add-ons.

    Common customization requests

    • Insert / payload: replace the gene/sequence, swap to a different isoform, add mutations, or optimize cloning features.
    • Expression design: change promoter (e.g., CMV/EF1α/PGK), add enhancers, or adjust regulatory elements.
    • Reporters: add/swap GFP/RFP/mCherry/luciferase (single or dual reporters where applicable).
    • Selection markers: add/swap puromycin/blasticidin/neomycin or fluorescent selection options.
    • Vector format: switch between OE, shRNA, CRISPR (sgRNA/Cas systems), or control vectors (where supported).

    Add-ons you can request

    • Control viruses: empty vector, non-targeting shRNA, reporter-only controls, or matched backbone controls.
    • Packaging / format: concentration options, aliquoting, or custom fill volume for screening workflows.
    • Documentation: construct map/sequence confirmation package (as available) and batch documentation.

    What to include in your request

    • Target cell type/model (cell line or primary cells) and intended readout (reporter, knockdown, OE, etc.)
    • Insert sequence (FASTA) or reference ID, plus any required tags/mutations
    • Promoter, reporter, and selection marker preferences
    • Desired scale and preferred format (aliquots / concentration requests)

    Email us at support@biohippo.com or use the Talk to a Scientist request form.

    Research budgets are tight — we get it. That's why we've put together a fresh round of exclusive promotions designed to help you stock up on the reagents, kits, and consumables your lab depends on, without stretching your budget.

    🔬 What's on offer right now:

    10% Off Pre-Designed siRNA Sets

    20% Off Transmembrane Proteins

    $50 Off All ELISA Kits

    50% Off Lab Consumables + Free Shipping

    $99 Pipette Filler Promotion Package

    BlasTaq 2X qPCR MasterMix - 50% OFF Limited Time Offer

    DENARASE® Endonuclease — 10% Off One Order

    10% OFF CELL LINES-Limited-Time Offer

    15% Off Proteins from Trusted Suppliers — Limited Time

    👉 Browse all current deals

    Get a Quote

    Please use this form for bulk quantity requests or customized products.

    Contact Information

    Product Information

    Supplier Ads Slides show

    Add dynamic ads with slider